Bacterial Disease Diagnostics Market Share

  • Report ID: 5206
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Market Share

North American Market Forecast

The market share of bacterial disease diagnostics in North America, is projected to be the largest with a share of about 35% by the end of 2036. The growth of the market can be attributed majorly to the rising instances of fatal infections caused by bacteria in the region. The growing changes in the climatic conditions have led to its warming and have significantly increased the chances of bacterial infections. According to the latest research performed by the University of East Anglia (UEA) in the United Kingdom, the United States has become the hotspot of bacterial illness. The frequency of V. vulnificus infections in the United States has increased from 10 to 80 annually over 30 years.

APAC Market Statistics

The Asia Pacific bacterial disease diagnostics market is estimated to be the second largest, registering a share of about 28% by the end of 2036. The growth of the market can be attributed majorly to the rising cases of typhoid in the region. In the rainy season, the climate in India becomes extremely humid, owing to which, every year typhoid cases witness a jump of 30% in the monsoon. The cases are higher in rural regions but in 2023, the cases significantly increased in urban areas as well.

Research Nester
Bacterial Disease Diagnostics Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5206
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of bacterial disease diagnostics is estimated at USD 3.46 Billion.

The bacterial disease diagnostics market size was valued at USD 3.23 Billion in 2023 and is set to cross USD 8.59 Billion by the end of 2036, expanding at more than 7.8% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

North America industry is projected to be the largest with a share of about 35% by 2036, due to rising instances of fatal infections caused by bacteria in the region.

bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample